PHSE is the leader in Italy in Healthcare distribution at controlled temperature +2/+8 °C, focusing on hospital, home and clinical laboratory channels. Through its Global Forwarding division PHSE moves high value drugs, clinical trials, biopharmaceuticals, APIs and radiopharmaceuticals – in compliance with current regulations – in imports and exports through a solid and continuous cold chain. In its little more than 20 years of history, it has been able to distinguish itself through the exclusive use of its own personnel and means of transport and its strong orientation towards innovation and the establishment of an active and sustainable cold chain model. Since its beginnings, it has developed in-house IT platforms for Web Tracking and Control Tower validated according to GAMP 5 and FDA CFR 21 part 11 by a qualified external company, aimed at guaranteeing complete real-time visibility of key transport parameters, without the use of external packaging, with a double benefit: both environmental and cost/time in transit activities.
In October 2021, PHSE acquired 100% of Duimex, thus enhancing its portfolio of high value-added services to support pharmaceutical research, clinical trials and patient access to innovative drugs in Italy and worldwide.